KBC Group NV

Position in GILD — Gilead Sciences, Inc.

CIK 1411133 Brussels, C9

Back to GILD Full portfolio

Position in GILD

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$373,463,655

-$24,781,739 QoQ

Shares Held

2,679,656

-17.4% QoQ

Ownership

0.216%

of shares outstanding

% of Portfolio

0.99%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

KBC Group NV holds $2,118,683,406 across 10 Drug Manufacturers - General names. GILD ranks #2 (17.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	576,203	$529,974,231
2	GILD	Gilead Sciences, Inc. This page	2,679,656	$373,463,655
3	JNJ	Johnson & Johnson	1,269,307	$310,269,402
4	BMY	Bristol Myers Squibb Co	4,009,205	$243,158,282
5	PFE	Pfizer Inc	8,471,914	$237,891,345
6	MRK	Merck & Co., Inc.	1,217,611	$146,466,425
7	ABBV	AbbVie Inc.	669,647	$145,641,525
8	AMGN	Amgen Inc	252,179	$88,729,180

All Filings in GILD

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$373,463,655	2,679,656	-17.4%	Shares	Defined	2026-05-07
2025-12-31	$398,245,394	3,244,626	+9.6%	Shares	Defined	2026-01-26
2025-09-30	$328,667,337	2,960,967	+26.4%	Shares	Defined	2026-01-20
2025-06-30	$259,634,589	2,341,793	+26.9%	Shares	Defined	2025-08-08
2025-03-31	$206,741,774	1,845,085	-10.5%	Shares	Defined	2025-04-25
2024-12-31	$190,427,035	2,061,568	-9.7%	Shares	Defined	2025-01-22
2024-09-30	$191,366,392	2,282,519	-37.1%	Shares	Defined	2024-11-06
2024-06-30	$248,863,289	3,627,216	+14.8%	Shares	Defined	2024-07-17
2024-03-31	$231,409,715	3,159,177	+122.2%	Shares	Defined	2024-05-08
2023-12-31	$115,160,574	1,421,560	+14.9%	Shares	Defined	2024-02-13
2023-09-30	$92,682,419	1,236,755	-14.6%	Shares	Defined	2024-02-15
2023-06-30	$111,555,355	1,447,455	+55.3%	Shares	Defined	2024-02-15
2023-03-31	$77,329,699	932,020	+9.3%	Shares	Defined	2024-02-14
2022-12-31	$73,207,728	852,740	+7.2%	Shares	Defined	2024-02-14
2022-09-30	$49,093,950	795,817	+3.6%	Shares	Defined	2024-02-15
2022-06-30	$47,463,774	767,898	+11.2%	Shares	Defined	2024-02-14
2022-03-31	$41,042,198	690,365	-23.7%	Shares	Defined	2024-02-14
2021-12-31	$65,735,575	905,324	+9.2%	Shares	Defined	2024-02-14
2021-09-30	$57,897,197	828,879	+32.0%	Shares	Defined	2021-11-10
2021-06-30	$43,236,574	627,891	+22.3%	Shares	Defined	2022-02-15
2021-03-31	$33,187,504	513,500	+8.2%	Shares	Defined	2022-02-14
2020-12-31	$27,638,951	474,407	-15.0%	Shares	Defined	2022-02-14
2020-09-30	$35,287,191	558,430	+5.3%	Shares	Defined	2022-02-14
2020-06-30	$40,796,742	530,241	-12.8%	Shares	Defined	2022-02-14
2020-03-31	$45,447,051	607,906	—	Shares	Defined	2020-05-04
No filing history on record for this holder in this stock.